platinum has been researched along with Cystadenocarcinoma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beller, U; Diamant, Y; Lavie, O; Neuman, M; Rosemann, E | 1 |
| Chen, JT; Fujimoto, I; Hamada, T; Hasumi, K; Hirai, Y; Nakayama, K; Shimizu, Y; Teshima, H; Yamauchi, K; Yokosuka, K | 1 |
| Adams, M; Fish, RG; Kerby, I; Shelley, MD | 1 |
1 review(s) available for platinum and Cystadenocarcinoma
| Article | Year |
|---|---|
Serous papillary adenocarcinoma of the endometrium. A unique entity with a grave prognosis. Case report and review of the literature.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cystadenocarcinoma; Doxorubicin; Endometrial Neoplasms; Fallopian Tubes; Female; Humans; Hysterectomy; Lymph Node Excision; Middle Aged; Ovariectomy; Platinum; Prognosis | 1993 |
2 other study(ies) available for platinum and Cystadenocarcinoma
| Article | Year |
|---|---|
[CDDP-ACR treatment in patients with recurrent ovarian cancer with prior chemotherapy containing CDDP--a preliminary study of a 14-day continuous infusion of CDDP with ACR].
Topics: Abdominal Neoplasms; Aclarubicin; Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cystadenocarcinoma; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Leukopenia; Lymphatic Metastasis; Middle Aged; Ovarian Neoplasms; Platinum; Recurrence; Remission Induction; Thrombocytopenia | 1989 |
Cystic fluid-platinum kinetics in ovarian cancer patients: relevance to cis-dichlorodiammine platinum (II) sensitivity testing in vitro.
Topics: Cisplatin; Cystadenocarcinoma; Female; Humans; Kinetics; Ovarian Neoplasms; Platinum; Time Factors | 1985 |